Funding news · Nov 12, 2026
Rymo Technologies Raises Undisclosed Funding from 1Crowd for Rehab Robotics
Rymo Technologies Secures Funding from 1Crowd
Rymo Technologies, a Navi Mumbai-based health-tech startup, has raised an undisclosed round of funding. The round included participation from 1Crowd. The funding amount and round type were not disclosed.
What Rymo Does
Founded in 2020, Rymo Technologies transforms physical rehabilitation through robotics, virtual reality, and AI. Its flagship Mobi-L system is a compact robotic mobility trainer for upper and lower limb neuro-rehabilitation, supporting stroke recovery and neurological conditions.
The company reports over 452 clinical installations, including at AIIMS, Apollo Hospitals, and Manipal Hospitals. Rymo has also received US FDA Class II medical device classification.
Deal Details
- Company: Rymo Technologies
- Round: Undisclosed
- Amount: Not disclosed
- Date: November 12, 2026
- Investors: 1Crowd
Why It Matters for Acquisition Watchers
Rymo operates in the rehabilitation robotics segment, where clinical validation and hospital relationships are significant barriers to entry. Its reported installation base across major Indian hospital groups and its FDA Class II classification give it a regulatory and commercial footprint that could be attractive to acquirers in medical devices, rehabilitation technology, or digital health.
The undisclosed nature of the round limits visibility into valuation and dilution, but the participation of 1Crowd signals continued investor interest in the company's robotics and VR-based rehabilitation platform.